{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:26:47Z","timestamp":1794266807869,"version":"4.9.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajo.2025.03.036","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T04:02:04Z","timestamp":1743048124000},"page":"50-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Ocular Features of VEXAS Syndrome: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7447","authenticated-orcid":false,"given":"Clare","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Pietris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zgaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.ajo.2025.03.036_bib0001","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.03.036_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: a disease perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.036_bib0003","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1093\/rheumatology\/keab524","article-title":"Atypical splice-site mutations causing VEXAS syndrome","volume":"60","author":"Templ\u00e9","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.036_bib0004","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/mrcr\/rxab021","article-title":"UBA1 and DNMT3A mutations in VEXAS syndrome: a case report and literature review","volume":"6","author":"Shaukat","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/IOP.0000000000002570","article-title":"Orbital inflammatory disease due to VEXAS syndrome: an entity to consider","volume":"40","author":"Ang","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.036_bib0007","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/01676830.2022.2126501","article-title":"Recurrent orbital inflammation associated with VEXAS syndrome","volume":"43","author":"Beecher","year":"2024","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12348-023-00362-1","article-title":"Recurrent superior orbital fissure syndrome associated with VEXAS syndrome","volume":"13","author":"Myint","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"9","key":"10.1016\/j.ajo.2025.03.036_bib0009","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/s41433-024-03014-3","article-title":"Ocular and orbital manifestations in VEXAS syndrome","volume":"38","author":"Abumanhal","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2025.03.036_bib0010","doi-asserted-by":"crossref","DOI":"10.51731\/cjht.2022.494","article-title":"Treatment Options for VEXAS Syndrome: Rapid Review","author":"Goring","year":"2022","journal-title":"Canadian Agency for Drugs and Technologies in Health"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.036_bib0011","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41409-022-01774-8","article-title":"Update on VEXAS and role of allogeneic bone marrow transplant: considerations on behalf of the Chronic Malignancies Working Party of the EBMT","volume":"57","author":"Gurnari","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2021.09.001","article-title":"Toward a pathophysiology inspired treatment of VEXAS syndrome","volume":"58","author":"Heiblig","year":"2021","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ajo.2025.03.036_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdcr.2022.02.022","article-title":"Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome","volume":"23","author":"Goyal","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS","volume":"149","author":"van der Made","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajo.2025.03.036_bib0015","unstructured":"Critical Appraisal Skills Programme. CASP Cohort Study Checklist. Accessed June 8, 2024. https:\/\/casp-uk.net\/casp-tools-checklists\/"},{"issue":"5","key":"10.1016\/j.ajo.2025.03.036_bib0017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bjh.18488","article-title":"Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience","volume":"199","author":"Al-Hakim","year":"2022","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.036_bib0018","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","article-title":"VEXAS syndrome in a woman","volume":"60","author":"Barba","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0019","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13256-023-04034-5","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report","volume":"17","author":"Belicard","year":"2023","journal-title":"J Med Case Rep"},{"issue":"26","key":"10.1016\/j.ajo.2025.03.036_bib0020","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ajo.2025.03.036_bib0021","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/art.42101","article-title":"Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series","volume":"74","author":"Campochiaro","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.ajo.2025.03.036_bib0022","first-page":"1449","article-title":"VEXAS syndrome: a report of three cases","volume":"40","author":"Ciferska","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"23","key":"10.1016\/j.ajo.2025.03.036_bib0023","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.3390\/jcm10235586","article-title":"USAID associated with myeloid neoplasm and VEXAS syndrome: two differential diagnoses of suspected adult onset Still's disease in elderly patients","volume":"10","author":"Delplanque","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.036_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/practneurol-2021-003031","article-title":"Autoinflammatory syndromes in neurology: when our first line of defence misbehaves","volume":"22","author":"Diprose","year":"2022","journal-title":"Pract Neurol"},{"issue":"10","key":"10.1016\/j.ajo.2025.03.036_bib0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.oftal.2023.07.003","article-title":"Episcleritis and periorbital edema secondary to VEXAS syndrome","volume":"98","author":"Fanlo","year":"2023","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"10","key":"10.1016\/j.ajo.2025.03.036_bib0026","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12882-024-03454-9","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report","volume":"25","author":"Fukuda","year":"2024","journal-title":"BMC Nephrol"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.036_bib0028","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s10067-022-06338-1","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review","volume":"41","author":"Guerrero-Berm\u00fadez","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0029","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pathol.2022.04.011","article-title":"Inflammatory pseudotumour arising secondary to VEXAS syndrome","volume":"55","author":"Holmes","year":"2023","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/imj.15742","article-title":"VEXAS syndrome: lessons learnt from an early Australian case series","volume":"52","author":"Islam","year":"2022","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.036_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002255","article-title":"Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients","volume":"8","author":"Khitri","year":"2022","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.036_bib0032","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","article-title":"Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan","volume":"80","author":"Kirino","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2025.03.036_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901063","article-title":"Case report: tocilizumab treatment for VEXAS syndrome with relapsing polychondritis: a single-center, 1-year longitudinal observational study in Japan","volume":"13","author":"Kunishita","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.036_bib0034","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.ajo.2025.03.036_bib0035","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1093\/rheumatology\/keab200","article-title":"A case of VEXAS syndrome manifesting as Kikuchi-Fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia","volume":"60","author":"Lee","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.ajo.2025.03.036_bib0036","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1097\/RLU.0000000000004770","article-title":"VEXAS syndrome with tracheal involvement but absence of vasculitis in FDG PET\/CT","volume":"48","author":"Lohaus","year":"2023","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.036_bib0037","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/IOP.0000000000002450","article-title":"An orbital manifestation of VEXAS syndrome","volume":"39","author":"Lokhande","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.ajo.2025.03.036_bib0038","article-title":"Case report: genetic double strike: VEXAS and TET2-positive myelodysplastic syndrome in a patient with long-standing refractory autoinflammatory disease","volume":"12","author":"Lotscher","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0039","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03009742.2022.2045791","article-title":"Orbital and periorbital inflammation in VEXAS syndrome","volume":"51","author":"Mart\u00edn-Nares","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ajo.2025.03.036_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108996","article-title":"Beh\u00e7et's disease with a somatic UBA1 variant: expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome","volume":"238","author":"Matsumoto","year":"2022","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0041","article-title":"A man in his sixties with chondritis and bone marrow failure","volume":"142","author":"Midtvedt","year":"2022","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.036_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-251089","article-title":"VEXAS syndrome with progression of MDS to MDS\/MPN overlap syndrome","volume":"15","author":"Neupane","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.036_bib0043","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/keae087","article-title":"Susceptibility to mycobacterial infection in VEXAS syndrome","volume":"64","author":"Riescher","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajo.2025.03.036_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2025.03.036_bib0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/labmed\/lmae020","article-title":"Bone marrow reinvestigation leading to the diagnosis of VEXAS syndrome","volume":"55","author":"Strasser","year":"2024","journal-title":"Lab Med"},{"issue":"8","key":"10.1016\/j.ajo.2025.03.036_bib0046","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2025.03.036_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152430","article-title":"Orbital\/ocular inflammatory involvement in VEXAS syndrome: data from the international AIDA network VEXAS registry","volume":"66","author":"Vitale","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.036_bib0048","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1097\/HS9.0000000000000661","article-title":"Azacytidine treatment for VEXAS syndrome","volume":"5","author":"Raaijmakers","year":"2021","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0049","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.41992","article-title":"VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis","volume":"74","author":"Muratore","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"26","key":"10.1016\/j.ajo.2025.03.036_bib0050","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.2020010286","article-title":"Novel somatic mutations in UBA1 as a cause of VEXAS syndrome","volume":"137","author":"Poulter","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.036_bib0051","article-title":"Adverse reaction to COVID-19 mRNA vaccination in a patient with VEXAS syndrome","volume":"14","author":"Ciprian","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.ajo.2025.03.036_bib0052","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/art.41775","article-title":"Extensive multiple organ involvement in VEXAS syndrome","volume":"73","author":"Takahashi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajo.2025.03.036_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109027","article-title":"SARS-CoV-2\/COVID-19 and its relationship with NOD2 and ubiquitination","volume":"238","author":"Rivera","year":"2022","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.ajo.2025.03.036_bib0054","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/ijd.16635","article-title":"Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings","volume":"62","author":"Hines","year":"2023","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.ajo.2025.03.036_bib0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/01658107.2024.2324387","article-title":"Painful diplopia as an initial presentation of VEXAS syndrome","volume":"48","author":"Zewar","year":"2024","journal-title":"Neuroophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.036_bib0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41927-023-00343-w","article-title":"A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma","volume":"7","author":"Vu","year":"2023","journal-title":"BMC Rheumatol"},{"issue":"9","key":"10.1016\/j.ajo.2025.03.036_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.70020","article-title":"A vexing case of a 73-year-old man with fevers, orbital cellulitis, and asymptomatic interstitial lung disease","volume":"12","author":"Agwan","year":"2024","journal-title":"Respirol Case Rep"},{"issue":"5","key":"10.1016\/j.ajo.2025.03.036_bib0058","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/IOP.0000000000002669","article-title":"Orbital compartment syndrome as a novel manifestation of VEXAS (Vacuole, E1 Enzyme, X-Linked, Autoimmune, Somatic Syndrome)","volume":"40","author":"Gupta","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"13","key":"10.1016\/j.ajo.2025.03.036_bib0059","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2022016985","article-title":"Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis","volume":"140","author":"Ferrada","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.036_bib0060","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1093\/rheumatology\/keac356","article-title":"Novel genetic mutation in myositis-variant of VEXAS syndrome","volume":"61","author":"Topilow","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0061","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2013.05.026","article-title":"Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study","volume":"156","author":"Homayounfar","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.03.036_bib0062","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ceo.13761","article-title":"Epidemiology of episcleritis and scleritis in urban Australia","volume":"48","author":"Thong","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.036_bib0063","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.seminhematol.2021.10.002","article-title":"VEXAS within the spectrum of rheumatologic disease","volume":"58","author":"Koster","year":"2021","journal-title":"Semin Hematol"},{"issue":"5","key":"10.1016\/j.ajo.2025.03.036_bib0064","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10875-022-01258-w","article-title":"A high-throughput amplicon screen for somatic UBA1 variants in cytopenic and giant cell arteritis cohorts","volume":"42","author":"Poulter","year":"2022","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.ajo.2025.03.036_bib0065","doi-asserted-by":"crossref","DOI":"10.1177\/019459987808600209","article-title":"Orbital complications of acute sinusitis: evaluation, management, and outcome","volume":"86","author":"Schramm","year":"1978","journal-title":"Otolaryngology"},{"issue":"13","key":"10.1016\/j.ajo.2025.03.036_bib0066","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.2022017560","article-title":"Lost in translation: cytoplasmic UBA1 and VEXAS syndrome","volume":"140","author":"Stubbins","year":"2022","journal-title":"Blood"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T08:54:13Z","timestamp":1751964853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":65,"alternative-id":["S0002939425001539"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.036","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Features of VEXAS Syndrome: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}